As a result, the present study revealed that CAT, the main active component of Rehmannia, protected against cerebral ischemia in vivo and in vitro by inhibiting neuronal injury and autophagy via the NRF1/KAT2A/METTL3/Beclin-1 axis (Fig. 8). The gene discussed is CAT; the disease is brain ischemia.